Stocks and Investing Stocks and Investing
Wed, February 26, 2020
Tue, February 25, 2020

Salim Syed Maintained (BIIB) at Hold with Increased Target to $316 on, Feb 25th, 2020


Published on 2024-10-26 22:35:41 - WOPRAI, Salim Syed
  Print publication without navigation


Salim Syed of Mizuho, Maintained "Biogen Inc." (BIIB) at Hold with Increased Target from $300 to $316 on, Feb 25th, 2020.

Salim has made no other calls on BIIB in the last 4 months.



There are 10 other peers that have a rating on BIIB. Out of the 10 peers that are also analyzing BIIB, 3 agree with Salim's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Evan Seigerman of "Credit Suisse" Maintained at Hold with Increased Target to $330 on, Thursday, February 6th, 2020
  • Mohit Bansal of "Wells Fargo" Maintained at Hold with Increased Target to $311 on, Thursday, February 6th, 2020
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Hold with Increased Target to $361 on, Thursday, February 6th, 2020


These are the ratings of the 7 analyists that currently disagree with Salim


  • Christopher Marai of "Nomura" Maintained at Strong Buy with Increased Target to $392 on, Friday, February 7th, 2020
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $410 on, Thursday, February 6th, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Increased Target to $302 on, Thursday, February 6th, 2020
  • Brian Skorney of "Baird" Maintained at Sell with Increased Target to $290 on, Thursday, February 6th, 2020
  • Robyn Karnauskas of "SunTrust Robinson Humphrey" Maintained at Strong Buy with Increased Target to $360 on, Monday, February 3rd, 2020
  • Sumant Kulkarni of "Canaccord Genuity" Upgraded from Hold to Strong Buy and Held Target at $360 on, Monday, January 27th, 2020
  • Aaron Gal of "Bernstein" Upgraded from Hold to Buy on, Wednesday, October 30th, 2019
Contributing Sources